Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(21)
•••
Post by Sinbobon Mar 18, 2013 1:04pm
170 Views
Post# 21146005

Nothing to do with BTI ...

Nothing to do with BTI ...

... but it does highlight an example of what has been and is going on in these markets. Yes, this guy got nailed and has been found guilty and made an example of but, if some little guy from Calgary can do it, imagine how many others there are .... and just imagine how successful the 'too big to jail'  criminals are. Even though 'Coffin Trader' has been found guilty, I can't help but think he is also a diversionary 'red Herring' sacrifice for the really big players. As for boards such as these, all must be taken with a huge grain of salt.

 

 

“Coffin Trader” found guilty of manipulating stocks:

 

https://www.albertasecurities.com/Enforcement/Enforcement%20Orders/DE%20GOUVEIA%20David%20DEC%202013%2003%2013%204456647v1.pdf

Some may have hear of the above. I wonder how many more there are out there?

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities